C/EBPδ targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 20, 2010, Pages 9210-9215

  Pawar, Snehalata A ^a,c   Sarkar, Tapasree Roy ^a   Balamurugan, Kuppusamy ^a   Sharan, Shikha ^a   Wang, Jun ^a   Zhang, Youhong ^a   Dowdy, Steven F ^b   Huang, A Mei ^a,d   Sterneck, Esta ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anaphase promoting complex; Breast cancer; Cdh1 FZR1; Cell cycle; Tumor suppressor

Indexed keywords

ANAPHASE PROMOTING COMPLEX; CCAAT ENHANCER BINDING PROTEIN DELTA; CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 27; CULLIN; CYCLIN B1; CYCLIN D1; F BOX PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; POLO LIKE KINASE 1; PROTEASOME; PROTEIN CUL1; S PHASE KINASE ASSOCIATED PROTEIN 2; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIUM CELL; FIBROBLAST; GENE SILENCING; GENOME; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; UBIQUITINATION;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN B1; CYCLIN D1; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOPRECIPITATION; MICE; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; S-PHASE KINASE-ASSOCIATED PROTEINS;

EID: 77952718207     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0913813107     Document Type: Article

References (42)

1. Agrawal S, et al. (2007) The C/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. Blood 109:3895-3905. (Pubitemid 46641742)
2. Ko CY, Hsu HC, Shen MR, Chang WC, Wang JM (2008) Epigenetic silencing of CCAAT/ enhancer-binding protein delta activity by YY1/polycomb group/DNA methyltransferase complex. J Biol Chem 283:30919-30932.
3. Porter D, et al. (2003) Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res 1:362-375. (Pubitemid 36437922)
4. Tang D, Sivko GS, DeWille JW (2006) Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors. Breast Cancer Res Treat 95:161-170.
5. Neve RM, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10:515-527.
6. O'Rourke JP, Newbound GC, Hutt JA, DeWille J (1999) CCAAT/enhancer- binding protein delta regulates mammary epithelial cell G0 growth arrest and apoptosis. J Biol Chem 274:16582-16589. (Pubitemid 129526418)
7. Gery S, Tanosaki S, Hofmann WK, Koppel A, Koeffler HP (2005) C/EBPdelta expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation. Oncogene 24:1589-1597. (Pubitemid 40396088)
8. Ikezoe T, et al. (2005) CCAAT/enhancer-binding protein delta: A molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells. Cancer Res 65:4762-4768. (Pubitemid 40740813)
9. Huang AM, et al. (2004) Loss of CCAAT/enhancer binding protein δ promotes chromosomal instability. Oncogene 23:1549-1557.
10. Barresi V, Vitarelli E, Cerasoli S, Barresi G (2010) The cell growth inhibitory transcription factor C/EBPdelta is expressed in human meningiomas in association with low histological grade and proliferation index. J Neurooncol 97:233-240.
11. Naderi A, et al. (2007) A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene 26:1507-1516. (Pubitemid 46340809)
12. Thangaraju M, et al. (2005) C/EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution. Development 132:4675-4685. (Pubitemid 41685278)
13. Roy PG, Thompson AM (2006) Cyclin D1 and breast cancer. Breast 15:718-727.
14. Wang TC, et al. (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671. (Pubitemid 24199473)
15. Yu Q, Geng Y, Sicinski P (2001) Specific protection against breast cancers by cyclin D1 ablation. Nature 411:1017-1021. (Pubitemid 32612319)
16. Grillo M, et al. (2006) Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression. Breast Cancer Res Treat 95:185-194.
17. Miller M, Shuman JD, Sebastian T, Dauter Z, Johnson PF (2003) Structural basis for DNA recognition by the basic region leucine zipper transcription factor CCAAT/ enhancer-binding protein alpha. J Biol Chem 278:15178-15184. (Pubitemid 36799852)
18. Pontano LL, et al. (2008) Genotoxic stress-induced cyclin D1 phosphorylation and proteolysis are required for genomic stability. Mol Cell Biol 28:7245-7258.
19. Shields BJ, Hauser C, Bukczynska PE, Court NW, Tiganis T (2008) DNA replication stalling attenuates tyrosine kinase signaling to suppress S phase progression. Cancer Cell 14:166-179.
20. Bonner WM, et al. (2008) GammaH2AX and cancer. Nat Rev Cancer 8:957-967.
21. Mah LJ, El-Osta A, Karagiannis TC (2010) gammaH2AX: A sensitive molecular marker of DNA damage and repair. Leukemia 24:679-686.
22. Alao JP (2007) The regulation of cyclin D1 degradation: Roles in cancer development and the potential for therapeutic invention. Mol Cancer 6:24.
23. Lamb J, et al. (2003) A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114:323-334.
24. Agami R, Bernards R (2000) Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102:55-66.
25. King RW, et al. (1995) A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell 81:279-288.
26. Sumara I, Maerki S, Peter M (2008) E3 ubiquitin ligases and mitosis: Embracing the complexity. Trends Cell Biol 18:84-94.
27. Peters JM (2006) The anaphase promoting complex/cyclosome: A machine designed to destroy. Nat Rev Mol Cell Biol 7:644-656.
28. Luo J (2009) Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett 273:194-200.
29. Wäsch R, Robbins JA, Cross FR (2010) The emerging role of APC/CCdh1 in controlling differentiation, genomic stability and tumor suppression. Oncogene 29:1-10.
30. Wang C, et al. (2003) Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation. Mol Cell Biol 23:6159-6173.
31. InoueK, Sherr CJ (1998)Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism. Mol Cell Biol 18:1590-1600.
32. Petre-Draviam CE, et al. (2005) A central domain of cyclin D1 mediates nuclear receptor corepressor activity. Oncogene 24:431-444.
33. Skaar JR, Pagano M (2009) Control of cell growth by the SCF and APC/C ubiquitin ligases. Curr Opin Cell Biol 21:816-824.
34. Lin DI, et al. (2006) Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF (FBX4-alphaB crystallin) complex. Mol Cell 24:355-366.
35. Pál M, Nagy O, Ménesi D, Udvardy A, Deák P (2007) Structurally related TPR subunits contribute differently to the function of the anaphase-promoting complex in Drosophila melanogaster. J Cell Sci 120:3238-3248.
36. Fujii Y, et al. (2006) Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation. Cancer Sci 97:729-736.
37. O'Rourke J, Yuan R, DeWille J (1997) CCAAT/enhancer-binding protein-delta (C/EBPdelta) is induced in growth-arrested mouse mammary epithelial cells. J Biol Chem 272: 6291-6296. (Pubitemid 27118102)
38. Umayahara Y, Ji C, Centrella M, Rotwein P, McCarthy TL (1997) CCAAT/enhancer-binding protein delta activates insulin-like growth factor-I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone. J Biol Chem 272:31793-31800. (Pubitemid 28013330)
39. Barbaro V, et al. (2007) C/EBPdelta regulates cell cycle and self-renewal of human limbal stem cells. J Cell Biol 177:1037-1049. (Pubitemid 46955708)
40. Kim JK, Diehl JA (2009) Nuclear cyclin D1: An oncogenic driver in human cancer. J Cell Physiol 220:292-296.
41. Freemantle SJ, et al. (2007) Cyclin degradation for cancer therapy and chemo-prevention. J Cell Biochem 102:869-877.
42. Takahashi-Yanaga F, Sasaguri T (2008) GSK-3beta regulates cyclin D1 expression: A new target for chemotherapy. Cell Signal 20:581-589. (Pubitemid 351241128)